Page last updated: 2024-08-24

dexmedetomidine and Carcinoma, Lewis Lung

dexmedetomidine has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ben-Eliyahu, S; Benbenishty, A; Cata, JP; Elbaz, E; Gottumukkala, V; Haldar, R; Lavon, H; Matzner, P; Rossene, E; Sorski, L	1

Other Studies

1 other study(ies) available for dexmedetomidine and Carcinoma, Lewis Lung

Article	Year
Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers. British journal of anaesthesia, 2018, Volume: 120, Issue:1 Topics: Adenocarcinoma; Adrenergic alpha-2 Receptor Agonists; Animals; Carcinoma, Lewis Lung; Colonic Neoplasms; Dexmedetomidine; Female; Hypnotics and Sedatives; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-2	2018

Article

Year

Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers.

British journal of anaesthesia, 2018, Volume: 120, Issue:1

Topics: Adenocarcinoma; Adrenergic alpha-2 Receptor Agonists; Animals; Carcinoma, Lewis Lung; Colonic Neoplasms; Dexmedetomidine; Female; Hypnotics and Sedatives; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-2

2018